全球不孕不育治疗设备市场 – 行业趋势及 2029 年预测

市场分析和规模

根据联合国的数据，到 2030 年，全球生育率预计将下降至每名妇女生育 2.4 个孩子，到 2050 年则降至每名妇女生育 2.2 个孩子。（联合国）。目前，全球 46% 的人口居住在生育率较低的国家。另有 46% 的人口居住在生育率中等的国家，最后 8% 的人口居住在生育率较高的国家。      

Data Bridge Market Research 分析，不孕症治疗设备和设备市场在 2021 年为 12.498 亿美元，到 2029 年将飙升至 25.0864 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 9.10%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

市场定义

不孕不育治疗器械市场以精子分离装置为主。在大多数辅助生殖技术中，如体外受精和人工授精，都会使用精子分离装置。这些仪器对辅助生殖技术至关重要，因为它们可以为后续手术提供纯净的样本。

报告范围和市场细分

Infertility Treatment Devices and Equipment Market Dynamics

Drivers

• Increasing Incidence of Infertility in Both Sexes

Infertility is defined by the World Health Organization as an individual's inability to achieve a healthy clinical pregnancy. Infertility can affect both men and women, however the majority of research on the problem has been conducted on women. The average number of children a woman has is referred to as her fertility rate. The global fertility rate is gradually declining due to a variety of variables, including an increase in late marriages and an increase in age-related infertility.

• Innovation and enhancement of technology

The success rate of treatments is increasing as technology improves. For example, increased demand for cryosystems and other associated devices will emerge from the development of storage equipment for temperature-sensitive sperm samples.

• Improvements in assisted reproductive treatments

Time-lapse imaging is one of the most cutting-edge infertility therapies. Time-lapse imaging can be utilised to examine the embryo development process at regular intervals without disturbing the culture. Embryos would be taken out of the incubator every day to be evaluated in earlier monitoring procedures. Embryos can continue in the incubator without disturbing their growth because to advances in technology and the usage of computers.

Opportunities

Many causes contribute to low conception rates, thus the number of people seeking infertility therapy will increase in the future years. Many companies have created novel devices and procedures for fertility treatment that are simple, effective, and cost-effective. The rising incidence of infertility in both sexes and the rising number of fertility clinics and infertility services with government assistance are key factors driving market expansion.

Restraints/Challenges

• Multiplicity and risk of preterm delivery

Several pregnancies are more likely when more than one foetus is transplanted to the mother's uterus during IVF infertility therapy, and if the babies are multiple, the risk of preterm delivery is higher. According to certain research, embryos that grow through IVF infertility treatment are born prematurely and weigh less than normal.

• Ovarian hyperstimulation syndrome

Infertile women utilise injectable fertility medicines like gonadotropins to help them ovulate during IVF infertility treatment. As a result, they develop ovarian hyperstimulation syndrome, which produces swollen and painful ovaries. Mild abdominal pain, bloating, nausea, diarrhoea, and vomiting are common symptoms of this syndrome, which subside after a week. Rapid weight gain and shortness of breath are ovarian hyperstimulation syndrome symptoms.

• Abortion

The rate of miscarriage in women who get pregnant through IVF is the same as it is in women who get pregnant naturally, although the rate of miscarriage rises with the mother's age.

This infertility treatment devices and equipment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infertility treatment devices and equipment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Infertility Treatment Devices and Equipment Market

COVID-19 sickness began to spread over the world in the first half of 2020, infecting millions of people globally, prompting major countries around the world to impose foot prohibitions and work stoppage orders. This report also examines the impact of the COVID-19 pandemic on the Infertility Treatment Devices and Equipment market, including supply chain analysis, impact assessments on the market size growth rate in various scenarios, and the measures that infertility treatment devices and equipment companies will take in response to the COVID-19 pandemic.

Global Infertility Treatment Devices and Equipment Market Scope

The infertility treatment devices and equipment market is segmented on the basis of type, procedure and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Ovum Aspiration Pumps
• Sperm Separation Devices
• Sperm Analyzer Systems
• Micromanipulator Systems
• Incubators
• Others

Procedure

• Assisted Reproductive Technology
• In Vitro Fertilization
• Intracytoplasmic Sperm Injection
• Others (GIFT, ZIFT, Surrogacy)
• Artificial Insemination
• Intrauterine Insemination
• Intratubal Insemination
• Intracervical Insemination
• Fertility Surgery
• Tubal Ligation Reversal
• Varicocelectomy
• Laparoscopy

Others (Laparotomy, Myomectomy, Microsurgical Reconstruction, Hysteroscopy)

终端用户

• 生育诊所
• 医院和其他医疗机构
• 临床研究机构

 不孕不育治疗设备和设备市场区域分析/见解

对不孕症治疗设备和器材市场进行了分析，并按国家、类型、程序和最终用户提供了市场规模见解和趋势。

不孕不育治疗设备和器械市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

2018 年，北美成为第二大市场，因为美国的生育率处于历史最低水平。根据美国国家卫生统计中心的数据，每 1,000 名女性仅有 62.5 名婴儿出生。

由于该地区不孕不育率的上升以及人们对可用治疗选择的认识不断提高，预计亚太地区将在未来几年以最快的速度发展。发达地区提供各种报销计划，预计将进一步促进区域扩张。例如，新加坡政府承担了多项 ART 手术费用的约 75%。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。 

医疗保健基础设施增长安装基础和新技术渗透

不孕不育治疗设备和器械市场还为您提供每个国家/地区资本设备医疗支出增长、不孕不育治疗设备和器械市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对不孕不育治疗设备和器械市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和不孕不育治疗设备市场份额分析

不孕不育治疗设备和器械市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对不孕不育治疗设备和器械市场的关注有关。

不孕不育治疗设备和器械市场的一些主要参与者包括：

• AB Scientific Ltd.（美国）
• Art Biotech Pvt. Ltd.（印度）
• 库克（美国）
• Dxnow, Inc.（美国）
• Eppendorf SE（美国）
• Esco Micro Pte. Ltd.（新加坡）
• Hamilton Thorne, Ltd.（美国）
• LabIVF Asia Pte Ltd.（新加坡）
• Rocket Medical plc（英国）
• 库博公司（美国）
• Vitrolife（瑞典）
• 尔湾科学公司（美国）
• Microptic（美国）
• 库博集团 (美国)

SKU-68244